Cargando…

Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers

BACKGROUND: Adult-onset Still’s disease (AOSD) is rare inflammatory disease of unknown etiology that usually affects young adults. The more common clinical manifestations are spiking fevers, arthritis, evanescent rash, elevated liver enzymes, lymphadenopathy, hepatosplenomegaly, and serositis. The m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruscitti, Piero, Cipriani, Paola, Masedu, Francesco, Iacono, Daniela, Ciccia, Francesco, Liakouli, Vasiliki, Guggino, Giuliana, Carubbi, Francesco, Berardicurti, Onorina, Di Benedetto, Paola, Valenti, Marco, Triolo, Giovanni, Valentini, Gabriele, Giacomelli, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131497/ https://www.ncbi.nlm.nih.gov/pubmed/27903264 http://dx.doi.org/10.1186/s12916-016-0738-8

Ejemplares similares

Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study
por: Ruscitti, Piero, et al.
Publicado: (2019)

Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy
por: Di Benedetto, Paola, et al.
Publicado: (2018)

Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study
por: Ruscitti, Piero, et al.
Publicado: (2017)

Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities
por: Ruscitti, Piero, et al.
Publicado: (2018)

Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study
por: Ruscitti, Piero, et al.
Publicado: (2017)

Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling
por: Di Benedetto, Paola, et al.
Publicado: (2019)

Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study
por: Ruscitti, Piero, et al.
Publicado: (2017)

The Role of IL-1β in the Bone Loss during Rheumatic Diseases
por: Ruscitti, Piero, et al.
Publicado: (2015)

Parenchymal lung disease in adult onset Still’s disease: an emergent marker of disease severity—characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients
por: Ruscitti, Piero, et al.
Publicado: (2020)

Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study
por: Carubbi, Francesco, et al.
Publicado: (2013)

Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature
por: Ruscitti, Piero, et al.
Publicado: (2015)

Searching for a good model for systemic sclerosis: the molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis
por: Cipriani, Paola, et al.
Publicado: (2016)

Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis
por: Cipriani, Paola, et al.
Publicado: (2014)

Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts
por: Cipriani, Paola, et al.
Publicado: (2015)

Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
por: Di Benedetto, Paola, et al.
Publicado: (2020)

IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study
por: Ruscitti, Piero, et al.
Publicado: (2019)

Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts
por: Liakouli, Vasiliki, et al.
Publicado: (2019)

Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features
por: Cipriani, Paola, et al.
Publicado: (2014)

Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6
por: Ruscitti, Piero, et al.
Publicado: (2022)

Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still’s disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort
por: Di Benedetto, Paola, et al.
Publicado: (2020)

Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis
por: Di Benedetto, Paola, et al.
Publicado: (2021)

Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm
por: Ruscitti, Piero, et al.
Publicado: (2020)

Downregulation of miRNA17–92 cluster marks Vγ9Vδ2 T cells from patients with rheumatoid arthritis
por: Guggino, Giuliana, et al.
Publicado: (2018)

Association Between Minor Salivary Gland Biopsy During Sjӧgren’s Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis
por: Berardicurti, Onorina, et al.
Publicado: (2021)

The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile
por: Ruscitti, Piero, et al.
Publicado: (2021)

Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations
por: Ruscitti, Piero, et al.
Publicado: (2020)

Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren’s syndrome minor salivary glands
por: Carubbi, Francesco, et al.
Publicado: (2019)

Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences
por: Ruscitti, Piero, et al.
Publicado: (2020)

Rheumatic manifestations of COVID-19: a systematic review and meta-analysis
por: Ciaffi, Jacopo, et al.
Publicado: (2020)

Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease
por: Ruscitti, Piero, et al.
Publicado: (2022)

Cytokine storm syndrome in severe COVID-19
por: Ruscitti, Piero, et al.
Publicado: (2020)

Incidence of venous thromboembolism in rheumatoid arthritis, results from a “real-life” cohort and an appraisal of available literature
por: Conforti, Alessandro, et al.
Publicado: (2021)

Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: a prospective open-label study
por: Pirrello, Roberto, et al.
Publicado: (2019)

Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study
por: Ruscitti, Piero, et al.
Publicado: (2019)

Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry
por: Ruscitti, Piero, et al.
Publicado: (2023)

Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis
por: Navarini, Luca, et al.
Publicado: (2022)

Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial
por: Ruscitti, Piero, et al.
Publicado: (2019)

Are Toll-Like Receptors and Decoy Receptors Involved in the Immunopathogenesis of Systemic Lupus Erythematosus and Lupus-Like Syndromes?
por: Guggino, Giuliana, et al.
Publicado: (2012)

The Pathogenic Role of Interferons in the Hyperinflammatory Response on Adult-Onset Still’s Disease and Macrophage Activation Syndrome: Paving the Way towards New Therapeutic Targets
por: Di Cola, Ilenia, et al.
Publicado: (2021)

Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren’s syndrome
por: Guggino, Giuliana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ohbtrra13uv2999l6f76v3kjhb